New York[email protected] | (212) 257-5802 | v-Card
Tim Opler is a Managing Director in Stifel’s Global Healthcare Group leading strategic and financing transactions across multiple healthcare sectors. Tim co-founded Torreya and became part of Stifel through the 2023 acquisition.For nearly 20 years, Tim has focused exclusively on life sciences advisory; he has completed more than 150 financing, licensing, and M&A transactions across the industry with a total value of over $100 billion. Highlights include running the largest share buyback in history for Pfizer, leading a $3.9 billion convertible bond exchange for Amgen, working on Chiron’s $5.1 billion sale to Novartis, and managing Genentech’s inaugural $2 billion bond issue.
Before co-founding Torreya, Tim was Vice President of Strategy at FibroGen, where he helped raise $117 million for the company and negotiated licensing deals. Previously, Tim was a Managing Director in Healthcare Investment Banking at Credit Suisse First Boston and held senior roles at W.R. Hambrecht, Deutsche Bank, and Merrill Lynch.
Prior to his career in investment banking, Tim was a professor in the finance department at Ohio State University. He earned a B.S. in Economics and Philosophy from Florida State University, and a Ph.D. in Economics from the University of California, Los Angeles.